Open original FDA record ↗Recall record
- FDA identifier
- Z-0223-2016
- Company in FDA record
- Bard Peripheral Vascular Inc
- FDA classification date
- Nov 5, 2015
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Bard Peripheral Vascular (BPV) is recalling the Bard Flair Endovascular Stent Graft because of the harm associated with failure to deploy or deployment related issues that could occur during use.
Source facts
- Action
- Bard sent an Urgent Medical Device Recall Notification letter dated October 19, 2015, to customers who received the Bard Flair Endovascular Stent Grant. The letter informs customers that the harm associated with failure to deploy or deployment related issues that could occur during use may pose an incremental risk to the already inherit risk associated with stent graft procedures. The letter also provides customers with the actions to be taken. Customers were instructed to call Bard Peripheral Vascular's (BPV) Recall Coordinator at 1-800-321-4254 Option #2 Ext 2501 (M-F 6am to 3pm MST). Customers were instructed to fax the Recall and Effectiveness Check Form to BPV at 1-800-994-6772.
- Initiated
- 2015-10-19
- Root cause
- Device Design
- Terminated
- 2016-04-12
- Distribution
- Nationwide in US
- Recall number
- Z-0223-2016
- Recall status
- Terminated
- CDRH record ID
- 141101
- FDA classified
- 2015-11-05
- Recall event number
- 72459